Articles and Publications

3 February 2025

Part IV of the Russian Civil Code governs legal protection of inventions and utility models. Russia is a member of the World Trade Organization, the World Intellectual Property Organization, the Paris Convention for the Protection of Industrial Property, the Patent Cooperation Treaty (PCT), the Patent Law Treaty, the Eurasian Patent Convention (EAPC), and a number of other international patent law treaties.

Read more

28 January 2025

In the article the author reports on the challenge of the Eurasian patent #024421 for the drug Osimertinib between the right holder AstraZeneca and the Russian drug manufacturer Axelpharm.

Read more

13 January 2025

Pharmaceutical products must go through research, clinical trials, and  registration with the health ministry or other  authorised government bodies, before going to the public. This multi-tiered composite procedure gave birth to extending  the term of patents directed to pharmaceutical  products up to 25 years in many jurisdictions. Circumstances surrounding such cases may present difficulties to the patent owner.

Read more

18 December 2024

In Russia, we sometimes see information in the foreign media that intellectual property (IP) in Russia has died, and no protection or enforcement of IP rights is possible. Aside from newspaper articles occasionally appearing in the media, we may see that allegation is repeated in the 14th package of restrictive measures issued by the Council Regulation (EU) or in the 2024 Special 301 Report issued by the Office of the United States Representative. One may wonder where that information comes from.

Read more

13 December 2024

Following the current political situation and the sanctions imposed on Russia, some Western companies decided to re-consider their trading and other business activities in Russia. Taking advantage of the moment, some market players, acting in bad faith, are attempting to register famous brands or their imitations in their own name without the consent of the real owners of those brands.

Read more